Zenas BioPharma, Inc. Common Stock Share Price
NASDAQ: ZBIO
Live Zenas BioPharma, Inc. Common Stock Share Price Chart
O H L
Zenas BioPharma, Inc. Common Stock Performance Overview
Days Range
▼
$26.78Low
$27.50High
Markets Today
| Previous Close | $26.24 |
|---|---|
| Open | $26.88 |
| Volume | 429,602 |
| Day's Range | $26.78 - $27.50 |
| 52W Range | NA |
| Market Cap | $1.71 B |
Historical Performance
| 1M Returns | -12.35 |
|---|---|
| 3M Returns | -5.15 |
| 6M Returns | +33.37 |
| 1Y Returns | +2.52 |
| 5Y Returns | NA |
| 10Y Returns | -36.04 |
Zenas BioPharma, Inc. Common Stock Fundamentals
| Market Cap | $1.71 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $10.00 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-383.00 M |
| Profit Margin | -3777.37 |
| Market Cap | $1.71 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $10.00 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-383.00 M |
| Profit Margin | -3777.37 |
Zenas BioPharma, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $10.00 M | $0 | $0 | $0 | $0 | $1.00 M |
| Gross Profit + | $10.00 M | $0 | $0 | $0 | $0 | $1.00 M |
| Operating Income | -$37.33 M | -$55.16 M | -$52.58 M | -$237.98 M | -$77.35 M | -$107.66 M |
| EBITDA | -$37.31 M | -$55.15 M | -$52.57 M | -$237.97 M | -$77.34 M | -$107.66 M |
| Interest Expense | $0 | $0 | $0 | -$7.33 M | -$368.00 K | -$8.56 M |
| Depreciation | $23.00 K | $12.00 K | $11.00 K | $10.00 K | $6.00 K | $4.00 K |
| Income Before Tax | -$33.78 M | -$52.20 M | -$51.50 M | -$240.34 M | -$80.99 M | -$111.34 M |
| Income Tax Expense | -$205.00 K | $20.00 K | $0 | $106.00 K | $0 | $114.00 K |
| Net Income + | -$33.57 M | -$52.22 M | -$51.50 M | -$240.44 M | -$80.99 M | -$111.46 M |
| Net Profit Margin | -335.73% | - | - | - | - | -11145.6% |
Zenas BioPharma, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $4.00 K | $4.00 K | $4.00 K | $5.00 K | $6.00 K | $6.00 K |
| Reserve & Surplus | -$420.82 M | -$473.28 M | -$524.75 M | -$765.19 M | -$846.49 M | -$958.71 M |
| Non-Current Liabilities | $317.00 K | $215.00 K | $73.17 M | $78.85 M | $350.69 M | $388.77 M |
| Current Liabilities | $49.13 M | $53.24 M | $52.42 M | $62.65 M | $61.16 M | $65.82 M |
| Total Liabilities | $49.45 M | $53.46 M | $125.59 M | $141.50 M | $411.85 M | $454.59 M |
| Fixed Assets | $72.00 K | $61.00 K | $50.00 K | $34.00 K | $28.00 K | $23.00 K |
| Current Assets | $317.81 M | $278.60 M | $296.64 M | $351.17 M | $730.16 M | $653.79 M |
| Total Assets | $333.77 M | $293.08 M | $322.02 M | $383.64 M | $747.68 M | $701.69 M |
Zenas BioPharma, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$33.57 M | -$52.22 M | -$51.50 M | -$240.44 M | -$80.99 M | -$111.46 M |
| Operating Cash Flow | -$37.05 M | -$41.74 M | -$41.13 M | -$52.41 M | -$75.20 M | -$57.24 M |
| Investing Cash Flow | -$86.27 M | -$112.29 M | $40.04 M | -$93.36 M | $31.61 M | -$287.70 M |
| Financing Cash Flow | $99.00 K | $1.72 M | $72.62 M | $140.84 M | $433.48 M | $42.06 M |
| Change in Cash | -$123.28 M | -$152.55 M | $71.56 M | -$4.92 M | $389.58 M | -$303.65 M |
Zenas BioPharma, Inc. Common Stock Return Calculator
The Zenas BioPharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Zenas BioPharma, Inc. Common Stock
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Popular Stocks
FAQs
What is the share price of Zenas BioPharma, Inc. Common Stock today?
Zenas BioPharma, Inc. Common Stock (ZBIO) share price as of October 10, 2026 is $25.04. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Zenas BioPharma, Inc. Common Stock?
Yes, Indian Investors can invest in the Zenas BioPharma, Inc. Common Stock (ZBIO) Share by opening an international trading account with Angel One.
How can I purchase Zenas BioPharma, Inc. Common Stock shares in India?
Purchasing Zenas BioPharma, Inc. Common Stock (ZBIO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Zenas BioPharma, Inc. Common Stock (ZBIO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Zenas BioPharma, Inc. Common Stock?
Yes, you can purchase fractional shares of Zenas BioPharma, Inc. Common Stock (ZBIO) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Zenas BioPharma, Inc. Common Stock?
The market capitalization of Zenas BioPharma, Inc. Common Stock on October 10, 2026, is $1.71 B.
In which sector Zenas BioPharma, Inc. Common Stock belongs?
Zenas BioPharma, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Zenas BioPharma, Inc. Common Stock stocks?
In order to invest in Zenas BioPharma, Inc. Common Stock (ZBIO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
